A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
Clinical trial NCT05584670 · RECRUITING
Trial details
- NCT number
- NCT05584670
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2027-01-19
- Enrollment
- 542
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.